Drug Research

Researchers from the University of Otago in New Zealand have taken advantage of a brain protein that has a strong chance of delaying or reversing the start of Alzheimer's disease. There are currently no viable treatments for Alzheimer's, according...

The pharmaceutical lobbying group's aura of invincibility has faded. The U.S. Senate recently passed a new bill, leaving the pharmaceutical sector licking its wounds and paving the way for a significant drug pricing overhaul. If the comprehensive climate and tax...

There were a lot of mysteries surrounding COVID-19, some of which have been answered, but many more have not. Since the start of the pandemic, it has been a mystery as to why children appear to be considerably less...

The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger RNA (mRNA) vaccines. The first job for the newly formed Working Party will be to produce...

AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way for billions in sales. This is the first-ever U.S. Food and Drug Administration (FDA) approval for...

Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method. The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...

Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form of the guidance, brolucizumab, also known as Beovu, is suggested as a treatment for adults...